회사 소개
Increase the Certainty of Drug Development Success
The drug discovery and development process is complex, with more failures than successes. As your trusted partner, we accelerate medicines to patients, using biosimulation (modeling and simulation) and technology-enabled services to transform drug discovery and development.
Our integrated and proprietary end-to-end platform with generative AI technology, biosimulation, regulatory science, and market access solutions combined with our global 1,400+ strong team of scientists and experts enable informed decision-making, higher R&D productivity, and improved patient outcomes. With our quantitative approach, we anticipate and address your critical drug discovery and development decisions:
- 안전성과 유효성을 최대화하기 위해 어떻게 용량을 최적화하나요?
- 임상시험의 성공 확률은 얼마나 되나요?
- 불확실성을 극복하기 위해 규제 당국과 어떻게 협력하나요?
- What’s the best way to assess and demonstrate the maximum value of a new therapy?
Certara는 면역항암제, 희소 질환, CNS, 호흡기 질환, 유전자 요법 및 전반적인 건강 상태를 포함한 모든 치료 영역과 혁신 요법에 걸쳐 작업하며 신약 발견에서 환자 접근성에 이르는 중개적 솔루션을 제공합니다.
Certara’s End-to-End Platform
>90%
지난 9년간 FDA의 신약 승인 중 90% 이상이 Certara 고객사
300+
지난 5년간 글로벌 규제 당국 및 보건 당국 제출 건수
60,000+
drug developers are end-users worldwide
회사 연혁
2008년에, Tripos International과 Pharsight Corporation이 함께 Certara를 설립했습니다. Since then, we have achieved incredible growth through acquisitions and the pharmaceutical industry and regulatory agencies’ adoption of model-informed drug development (MIDD).
Today, we are the global leader in biosimulation.
We can help you go farther, faster. Wherever you are in your drug development journey, Certara can help you improve decision-making.
Image Credit: JUSTIN LANE/EPA-EFE/Shutterstock
Unmatched MIDD Expertise at Scale
Certara 작업의 높은 품질은 헌신, 협력 및 깊은 전문성의 결과입니다.
With Certara, your partners are experts who are committed to finding the right answers and increasing the probability of your success.
Certara는 귀사의 목표를 추구하기 위해 최고의 과학자 및 전문가와 함께 완벽한 실행과 관리를 통해 복잡성을 해결합니다.
고객을 최우선으로
Your success is our guiding principle. Trusted by more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries, we are members of your team.
Certara는 정량적 과학과 다음과 같은 통합적 접근 방식을 통해 신약 개발 전략을 설계하고 구현합니다.
- 신속하게 개념 증명 가능
- 임상시험 설계 최적화
- 임상시험 규모 축소 또는 특정 임상시험의 완전한 생략
- 신속한 규제 문서 제출
- 의약품에 대한 환자의 접근성 확장
Recognized as an Employer of Choice
We foster a culture of excellence that is reflected in our reputation and achievement. For two years in a row, Certara has been Certified as a Great Place to Work. In fact, 88% of Certara employees say it is a great place to work compared to 57% of employees at a typical U.S.-based company.
도움이 필요하신가요?
Certara와 상담 시작하기
